Literature DB >> 10468869

Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis.

M Cazzola1, Y Beguin, G Bergamaschi, R Guarnone, P Cerani, S Barella, A Cao, R Galanello.   

Abstract

Congenital anaemias due to ineffective erythropoiesis may be associated with excessive iron absorption and progressive iron loading. We investigated whether the soluble transferrin receptor (TfR) level was related to the degree of iron overload in 20 patients with thalassaemia intermedia, six patients with congenital dyserythropoietic anaemia type II (CDA II) and four patients with X-linked congenital sideroblastic anaemia (XLSA). All but two patients had increased serum ferritin levels (median 601 microgram/l, range 105-2855 microgram/l). Multiple regression analysis showed that 62% (P < 0.0001) of the variation in serum ferritin was explained by age and by changes in soluble TfR.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468869     DOI: 10.1046/j.1365-2141.1999.01600.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  13 in total

1.  Is erythroferrone finally the long sought-after systemic erythroid regulator of iron?

Authors:  Alfons Lawen
Journal:  World J Biol Chem       Date:  2015-08-26

2.  Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.

Authors:  Raffaella Origa; Mario Cazzola; Elisabetta Mereu; Fabrice Danjou; Susanna Barella; Nicolina Giagu; Renzo Galanello; Dorine W Swinkels
Journal:  Haematologica       Date:  2015-01-16       Impact factor: 9.941

Review 3.  Hereditary hemochromatosis and transferrin receptor 2.

Authors:  Juxing Chen; Caroline A Enns
Journal:  Biochim Biophys Acta       Date:  2011-08-16

4.  Therapeutic effects of induced pluripotent stem cells in chimeric mice with β-thalassemia.

Authors:  Guanheng Yang; Wansheng Shi; Xingyin Hu; Jingzhi Zhang; Zhijuan Gong; Xinbing Guo; Zhaorui Ren; Fanyi Zeng
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

5.  Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin.

Authors:  Damien R Ashby; Daniel P Gale; Mark Busbridge; Kevin G Murphy; Neill D Duncan; Tom D Cairns; David H Taube; Stephen R Bloom; Frederick W K Tam; Richard Chapman; Patrick H Maxwell; Peter Choi
Journal:  Haematologica       Date:  2009-10-14       Impact factor: 9.941

6.  Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Authors:  Hannah Tamary; Hanna Shalev; Galit Perez-Avraham; Meira Zoldan; Itai Levi; Dorine W Swinkels; Toshihiko Tanno; Jeffery L Miller
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

7.  Iron Loading and Overloading due to Ineffective Erythropoiesis.

Authors:  Toshihiko Tanno; Jeffery L Miller
Journal:  Adv Hematol       Date:  2010-05-11

8.  Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.

Authors:  Ilaria Ambaglio; Luca Malcovati; Elli Papaemmanuil; Coby M Laarakkers; Matteo G Della Porta; Anna Gallì; Matteo C Da Vià; Elisa Bono; Marta Ubezio; Erica Travaglino; Riccardo Albertini; Peter J Campbell; Dorine W Swinkels; Mario Cazzola
Journal:  Haematologica       Date:  2013-01-08       Impact factor: 9.941

Review 9.  Iron homeostasis: recently identified proteins provide insight into novel control mechanisms.

Authors:  An-Sheng Zhang; Caroline A Enns
Journal:  J Biol Chem       Date:  2008-08-29       Impact factor: 5.157

10.  Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant.

Authors:  Michelle Pirotte; Marianne Fillet; Laurence Seidel; Aurélie Jaspers; Fréderic Baron; Yves Beguin
Journal:  Am J Hematol       Date:  2021-08-24       Impact factor: 13.265

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.